Características de los fármacos antirretrovirales
Authors:
- Esteban RiberaEREsteban Ribera
- Montse TusetMTMontse Tuset
- 1 May 2011
- journal article
- abstracts
- Published by Elsevier in Enfermedades Infecciosas y Microbiología Clínica
- Vol. 29 (5) , 362-391
Abstract
No abstract availableKeywords
This publication has 35 references indexed in Scilit:
- Total Raltegravir Concentrations in Cerebrospinal Fluid Exceed the 50-Percent Inhibitory Concentration for Wild-Type HIV-1Antimicrobial Agents and Chemotherapy, 2010
- Documento de consenso del Grupo de Estudio de Sida/Plan Nacional sobre el Sida respecto al tratamiento antirretroviral en adultos infectados por el virus de la inmunodeficiencia humana (actualización enero 2010)Enfermedades Infecciosas y Microbiología Clínica, 2010
- Pharmacokinetics and drug–drug interactions of antiretrovirals: An updateAntiviral Research, 2010
- Low atazanavir concentrations in cerebrospinal fluidAIDS, 2009
- Papel actual de tenofovir en la clínicaEnfermedades Infecciosas y Microbiología Clínica, 2008
- Systematic review of clinical trials evaluating low doses of stavudine as part of antiretroviral treatmentExpert Opinion on Pharmacotherapy, 2007
- Didanosine Enteric-Coated CapsuleDrugs, 2007
- An updated systematic overview of triple combination therapy in antiretroviral-naive HIV-infected adultsAIDS, 2006
- Emtricitabine, a New Antiretroviral Agent with Activity against HIV and Hepatitis B VirusClinical Infectious Diseases, 2006
- Abacavir plus LamivudineDrugs, 2005